Profile
Massimiliano Colao formerly worked at Amgen, Inc., as Vice President-Inflammation Sales, Abeona Therapeutics, Inc., as Chief Commercial Officer from 2018 to 2020, Alexion Pharmaceuticals, Inc., as Senior Vice President-US Commercial Operations from 2014 to 2017, and Aurinia Pharmaceuticals, Inc., as Chief Commercial Officer from 2020 to 2022.
Mr. Colao received his Masters Business Admin degree from the University of Southern California and undergraduate degree from the University of California, Los Angeles.
Former positions of Massimiliano Colao
| Companies | Position | End |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 14/07/2022 |
| ABEONA THERAPEUTICS INC. | Corporate Officer/Principal | 31/12/2019 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/12/2016 |
| AMGEN INC. | Corporate Officer/Principal | 31/12/2012 |
Training of Massimiliano Colao
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Abeona Therapeutics, Inc.
Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
- Stock Market
- Insiders
- Massimiliano Colao
















